Drug susceptibility tests for Mycobacterium tuberculosis

  • César Ugarte Gil Universidad Peruana Cayetano Heredia
  • Mario Ponce Alvarez Universidad Peruana Cayetano Heredia
  • David A. J. Moore Universidad Peruana Cayetano Heredia
Keywords: Tuberculosis, Drug susceptibility tests, Diagnosis

Abstract

Inadequate treatment regimens and poor compliance have led to increased rates of drug resistance in Mycobacterium tuberculosis around the world, leading to the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) strains. In Peru MDR-TB rates are amongst the highest in the world and XDR-TB cases have been reported for almost a decade. Drug susceptibility tests detect cases with resistant strains, providing the best treatment option to the patient and diminishing the spread of the disease. This review is directed at the non-specialist physician, focusing upon the drug susceptibility tests approved by the National TB Program of Peru and others currently still under research.

Downloads

Download data is not yet available.
Published
2020-08-09
How to Cite
1.
Ugarte Gil C, Ponce Alvarez M, J. Moore DA. Drug susceptibility tests for Mycobacterium tuberculosis. Acta Med Peru [Internet]. 2020Aug.9 [cited 2024Nov.24];25(3):171 -175. Available from: http://54.39.98.165/index.php/AMP/article/view/1428
Section
REVIEW ARTICLE